Biomedical Innovation The Master of Biomedical Innovation (MBioInno) programme, offering two specialised streams, Cellular and Molecular Biotechnology (CMB) and Digital Health Technology (DHT), features core and foundation courses in innovation management, technology transfer and industry or research experience, and aims to equip graduates to translate fundamental biomedical advances into innovative technologies that impact healthcare and industry. Interdisciplinary training in entrepreneurial and industry skills, and biomedical and AI knowledge Capstone project under HKU academic supervision or an industry internship Innovator Immersion Programme for full‑time students to enhance experiential learning in biomedical innovation Choice of two major streams: Cellular and Molecular Biotechnology (CMB), and Digital Health Technology (DHT) Unique Features MBioInno Programme Overview 21
RkJQdWJsaXNoZXIy Mzg4NDg0